JP2022541441A5
(cg-RX-API-DMAC7.html )
2023-07-21
JP2022548943A5
(cg-RX-API-DMAC7.html )
2023-10-03
JP2022510207A5
(cg-RX-API-DMAC7.html )
2022-12-12
JP2022550899A5
(cg-RX-API-DMAC7.html )
2023-10-17
JP2023505206A5
(cg-RX-API-DMAC7.html )
2023-12-11
JP2021505131A5
(cg-RX-API-DMAC7.html )
2022-01-11
JP2023548467A5
(cg-RX-API-DMAC7.html )
2024-11-13
Maher
2012
Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cells
KR102608966B1
(ko )
2023-12-04
세포 치료요법을 위한 항상성 활성 사이토킨 수용체
JP2023548829A5
(cg-RX-API-DMAC7.html )
2024-11-12
JP2023530704A5
(cg-RX-API-DMAC7.html )
2024-06-25
JP2023549098A5
(cg-RX-API-DMAC7.html )
2024-11-13
ES2692206T3
(es )
2018-11-30
Inmunoterapia combinada de receptores de reconocimiento de antígenos y células hematopoyéticas para el tratamiento de enfermedades
ES2867224T3
(es )
2021-10-20
Etiquetas genéticas transgénicas y métodos de uso
Thakur et al.
2010
Cancer therapy with bispecific antibodies: Clinical experience
US20230210905A1
(en )
2023-07-06
T cell-antigen coupler with various construct optimizations
JP2023545992A5
(cg-RX-API-DMAC7.html )
2024-10-17
CN105339498A
(zh )
2016-02-17
癌症中靶向cd138
JP7319250B2
(ja )
2023-08-01
Strep-タグ特異的結合タンパク質およびその使用
JP7701453B2
(ja )
2025-07-01
固形腫瘍標的化骨格を有する細胞及びその使用
JP2025105605A5
(cg-RX-API-DMAC7.html )
2026-05-22
JP2024515920A5
(cg-RX-API-DMAC7.html )
2024-08-15
KR20220003041A
(ko )
2022-01-07
조합 치료법
JP2024526237A5
(cg-RX-API-DMAC7.html )
2025-07-09
JP2024543024A5
(cg-RX-API-DMAC7.html )
2025-11-17